Frontiers in Neuroscience, 2012 · DOI: 10.3389/fnins.2012.00013 · Published: February 6, 2012
Oligodendrocytes create myelin sheaths around nerve fibers in the central nervous system, which is vital for proper nerve function. Damage to these cells leads to diseases like multiple sclerosis. MicroRNAs (miRNAs) are small molecules that control gene expression and play a crucial role in how oligodendrocytes develop. MiRNAs affect various aspects of oligodendrocyte development, including how they multiply, specialize, and form myelin. Understanding how miRNAs work could help in treating diseases where myelin is damaged. This review discusses how miRNAs regulate myelination and their potential role in demyelinating diseases. It also highlights the connection between miRNAs and the regulatory networks involved in myelination.
Targeting specific miRNAs could offer novel therapeutic interventions for myelin repair in demyelinating diseases.
MiRNA expression profiles can be used as potential biomarkers for diagnosing and monitoring demyelinating diseases like multiple sclerosis.
Further research into miRNA function will provide insights into the regulatory networks controlling myelination and the pathogenesis of demyelinating diseases.